Multimodal approaches to improve immunotherapy in breast cancer

María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell, Juan Miguel Cejalvo, Vanesa Pons, Begoña Bermejo, Miguel Martín, Joan Albanell, Ana Lluch, Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature Critical Reviews in Oncology Hematology. ,vol. 97, pp. 96- 106 ,(2016) , 10.1016/J.CRITREVONC.2015.08.011

Hui Xu, Guang-Xian Zhang, Bogoljub Ciric, Abdolmohamad Rostami, IDO: A double-edged sword for TH1/TH2 regulation Immunology Letters. ,vol. 121, pp. 1- 6 ,(2008) , 10.1016/J.IMLET.2008.08.008

Gillian M. Keating, Bevacizumab: A Review of Its Use in Advanced Cancer Drugs. ,vol. 74, pp. 1891- 1925 ,(2014) , 10.1007/S40265-014-0302-9

C. Sotiriou, S.-Y. Neo, L. M. McShane, E. L. Korn, P. M. Long, A. Jazaeri, P. Martiat, S. B. Fox, A. L. Harris, E. T. Liu, Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 10393- 10398 ,(2003) , 10.1073/PNAS.1732912100

Ernest S. Smith, Alan Jonason, Christine Reilly, Janaki Veeraraghavan, Terrence Fisher, Michael Doherty, Ekaterina Klimatcheva, Crystal Mallow, Chad Cornelius, John E. Leonard, Nicola Marchi, Damir Janigro, Azeb Tadesse Argaw, Trinh Pham, Jennifer Seils, Holm Bussler, Sebold Torno, Renee Kirk, Alan Howell, Elizabeth E. Evans, Mark Paris, William J. Bowers, Gareth John, Maurice Zauderer, SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease. Neurobiology of Disease. ,vol. 73, pp. 254- 268 ,(2015) , 10.1016/J.NBD.2014.10.008

Shih Ling HWANG, Nancy Pei-Yee CHUNG, Jacqueline Kwai-Yi CHAN, Chen-Lung Steve LIN, Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. Cell Research. ,vol. 15, pp. 167- 175 ,(2005) , 10.1038/SJ.CR.7290282

Padmanee Sharma, James P. Allison, The future of immune checkpoint therapy Science. ,vol. 348, pp. 56- 61 ,(2015) , 10.1126/SCIENCE.AAA8172

Karin Fischer, Petra Hoffmann, Simon Voelkl, Norbert Meidenbauer, Julia Ammer, Matthias Edinger, Eva Gottfried, Sabine Schwarz, Gregor Rothe, Sabine Hoves, Kathrin Renner, Birgit Timischl, Andreas Mackensen, Leoni Kunz-Schughart, Reinhard Andreesen, Stefan W. Krause, Marina Kreutz, Inhibitory effect of tumor cell–derived lactic acid on human T cells Blood. ,vol. 109, pp. 3812- 3819 ,(2007) , 10.1182/BLOOD-2006-07-035972

F Fallarino, U Grohmann, C Vacca, R Bianchi, C Orabona, A Spreca, M C Fioretti, P Puccetti, T cell apoptosis by tryptophan catabolism. Cell Death & Differentiation. ,vol. 9, pp. 1069- 1077 ,(2002) , 10.1038/SJ.CDD.4401073

Jose Rafael Sierra, Simona Corso, Luisa Caione, Virna Cepero, Paolo Conrotto, Alessandro Cignetti, Wanda Piacibello, Atsushi Kumanogoh, Hitoshi Kikutani, Paolo Maria Comoglio, Luca Tamagnone, Silvia Giordano, None, Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. Journal of Experimental Medicine. ,vol. 205, pp. 1673- 1685 ,(2008) , 10.1084/JEM.20072602